Last reviewed · How we verify

NCT05051176

Prevalence of Diastasis m. Rectus Abdominis in Postpartum Women

Completed Last updated 7 July 2022
What this trial tests

trial testing 2D usg and 3D/4D usg in Diastasis of m. Rectus Abdominis in 150 participants. Completed in 23 May 2022.

Timeline
8 April 2021
Primary endpoint
28 April 2022
23 May 2022

Quick facts

Lead sponsorPavol Jozef Safarik University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment150
Start date8 April 2021
Primary completion28 April 2022
Estimated completion23 May 2022
Sites1 location across Slovakia

Drugs / interventions tested

Conditions studied

Sponsor

Pavol Jozef Safarik University

Who can join

Adults 18 to 40, female only, with Diastasis of m. Rectus Abdominis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will evaluate the prevalence of diastasis m. rectus abdominis after delivery. Relationship of Diastasis Recti Abdominis with urine leakage, pelvic floor muscle function and morphometry in postpartum women.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Pavol Jozef Safarik University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05051176.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing